Clinical Trial Update: Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing aliskiren and amlodipine in hypertensive patients with metabolic syndrome, evaluating effects on insulin resistance and endothelial func…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Hypertension
• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: High Blood Pressure, Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2011-08-11